The Answer to the Threatened Avian Flu Pandemic may be Under Our Nose

Share Article

If the outcomes of a preliminary study completed by a small Ohio biotech company can be quantified, the ability to respond efficiently to the dreaded Avian Flu may be right under our noses.

The Impact of Emerging Technologies: Can Pfizer Deliver.

Albany, Ohio - February 17, 2006 –     If the outcomes of an exploratory study completed by a small Ohio biotech company can be quantified, the ability to respond efficiently to the dreaded Avian Flu may be right under our noses. Using anomalous vocal patterns, the acoustic architecture of the voice is being uniquely investigated for its potential to model biological function, disease process and environmental exposures.

As remarkable as this idea may seem, groundbreaking studies have shown that the acoustic parameters of the voice have the capacity to provide biometric information regarding states of health. Omeris, a non-profit organization founded to build and accelerate bioscience research in Ohio, has recognized that vocal acoustic studies conducted by Sharry Edwards, MEd., through her company Sound Health, Inc., have “brought a revolutionary idea to the forefront of the Bioscience Community.” Preliminary studies completed by Edwards included vocal studies for exposures and susceptibility to invading pathogens.

Like any other contagion, the Avian Flu has an incubation period before actual symptoms occur. If exposure could be verified using vocal samples while the pathogen is still in its incubation stage, it is highly likely that destructive proteins created by the pathogen could be predicted before they become destructive.

The therapeutic potential of vocal profiling is the identification of pre-diagnostic biometrics which can be used to enhance or render inert, disease based biomarkers depending on the desired outcome. The research protocols have also provided information that can be used to develop a therapy phase using a set of designer frequencies which precisely targets a specific normalizing response.

The genomic frequencies and associated proteins associated with the threatened bird flu pandemic have been decoded by Edwards and her team, but as yet there is no general structure in place to allow the public to use the procedure.    

Assuming that the exploratory investigations with resistant pathogens can be extrapolated to encompass the Avian flu, this research modality may provide a means to identify the frequency signatures of the current strains and the on-going mutations in a matter of minutes.

One of the most important projects being slated is the development of an on-line vocal sampling program that could gather research data by testing for toxin or pathogen exposure. Using this method, strategically located centers throughout the world could systematically sample vocal patterns that would be reported to a central location. Exposure to the bird flu viruses could be monitored through established mathematical templates derived from the acoustic measurements of individuals or groups suspected of contamination.

Government and medical authorities have been uncertain that vaccination and/or antibiotic measures can successfully counter the unpredictable conduct, or the severity of the expected pandemic. With an annihilation threat as high as 40% for many populations, it is imperative that researchers be provided the means to explore solutions presently beyond the conventional medical system. All viable remedies need to be made available to the public in order to quell the near panic that is ensuing in some countries.

To date, Sound Health has supported the costs of this research but immediate funding for the expansion of systematic vocal profiling as a potential avenue to combat the expected epidemic needs to be vigorously applied. The risk to public health makes such funding mandatory. If the reported pandemic risks are authentic, our national security may depend on it.

A premier public issue of the peer-reviewed Journal BioAcoustic Biology(TM) can be found at Sound Health can be reached via email at: or by phone at: 740-698-9119.

About Vocal Sampling and Analysis

Vocal analysis has been used experimentally by Sound Health for over twenty years to create individual frequency-based profiles that have supported outcomes that would be considered improbable using current medical standards.

For instance, independent nerve-muscle conduction tests (EMG’s) have confirmed the reestablishment of nerve transmission from the waist down for a Multiple Sclerosis patient who used vocal analysis and directed sound presentation as his primary therapy.

Vocal analysis has been used during two pilot studies to create protocols that were used to relieve the unrelenting fibromyalgia and back pain for long term sufferers.

Several prestigious research facilities have begun to embrace the innovative modality of vocal profiling to test the effects of new drugs, hormone levels and other biometric features of the body. The results promise to add significant confirmation to the idea that our bodies constitute a predictable system of BioAcoustic Biology(TM). Thus far, no research facility other than Sound Health has reported both pre-diagnostic and therapeutic outcomes based on vocal profiling.

Like Chemistry, that uses elements and compounds as its basis, BioAcoustic Biology uses vocal acoustics as the foundation to explain our frequency-based biological system. This methodology, christened Sonistry by Edwards, has the potential to significantly expand our understanding of the human body as a collection of predictable math-based compilations.

Edwards’ work has been received with both skepticism and admiration, but once the outcomes are observed, and they are significant and impressive to even the casual observer, the efficacy and reliability is obvious. Roman Chrucky, an MD who works with Edwards states, “Sharry has always been at least twenty years ahead of the rest of us. The world just needs to catch up to her genius.”

The frequency based principles of the voice are currently being investigated by many health related organizations such as Pfizer Pharmaceuticals and the Institute of Automatic Control Engineering in Taiwan. Complementary research, relating to molecular frequencies of both healthy and unhealthy cellular chemistry is being studied by James Gimjewski of the UCLA’s Department of Chemistry and Biochemistry.    Edwards believes that her contributions to the field of BioAcoustic Biology will show that human biology can be evaluated using the universal language of mathematics. Her supporters believe that her seminal work will be intimately involved in moving medicine forward.

Logically the establishment of a reliable model of BioAcoustic Biology, based on the quantitative analysis of human vocal patterns, will follow as a result of this emerging biometric approach to biological function, disease process and metabolism.


01. Rotman, David: “The Impact of Emerging Technologies: Can Pfizer Deliver.” Technology Review February, (2004).

02. Chiu CC, Chang HH, Yang CH. “Objective auscultation for traditional Chinese medical diagnosis using novel acoustic parameters.” Comput Methods Programs Biomed. Jun;62(2) (2000): 99-107.

03. Boguslavsky, J. “Biomarkers as Checkpoints.” Drug Discovery & Development. Sept (2004).            

04. Moore, C, S Shalet, K Manickam, T Williard, H Maheshwari, and G Baumann. "Voice abnormality in adults with congenital and adult-acquired growth hormone deficiency." J Clin Endocrinol Metab 90(7) (2005): 4128-4132.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

J Robert Bethel JD
Email >